IT1250749B - Composti eterociclici ad attivita' a ii antagonista - Google Patents
Composti eterociclici ad attivita' a ii antagonistaInfo
- Publication number
- IT1250749B IT1250749B ITMI912182A ITMI912182A IT1250749B IT 1250749 B IT1250749 B IT 1250749B IT MI912182 A ITMI912182 A IT MI912182A IT MI912182 A ITMI912182 A IT MI912182A IT 1250749 B IT1250749 B IT 1250749B
- Authority
- IT
- Italy
- Prior art keywords
- antagonist
- alkyl
- heterocyclic compounds
- optionally substituted
- compounds activated
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Composti di formula I (FORMULA I) con R = C1-C4 alchile; R1 = H, C1-C4 alchile, arile o aralchile eventualmente sostituiti; R2 = H, C1-C4 alchile, OH, NH2 o arile eventualmente sostituito; R3 = alogeno; X = CO, C-OR1 o C-CH2OR5, con R5 = H, C1-C4 alchile o aralchile eventualmente sostituito; e Z = carbossile, alcossicarbonile o tetrazol-5-ile; sono dotati di proprietà A II antagonisti e si prestano per la terapia di patologie cardiache e vascolari.
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI912182A IT1250749B (it) | 1991-08-02 | 1991-08-02 | Composti eterociclici ad attivita' a ii antagonista |
SK106-94A SK10694A3 (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine ii antagonistic activity |
RU9494015173A RU2098411C1 (ru) | 1991-08-02 | 1992-08-03 | Производные пиримидина, способ их получения, фармацевтическая композиция на их основе |
EP92916506A EP0641329A1 (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine ii antagonistic activity |
CZ94169A CZ16994A3 (en) | 1991-08-02 | 1992-08-03 | Heterocyclic compounds and pharmaceutical preparations in which they are comprised |
RO94-00144A RO113987B1 (ro) | 1991-08-02 | 1992-08-03 | Derivati de pirimidin-6-ona |
PCT/EP1992/001753 WO1993003018A1 (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine ii antagonistic activity |
JP5503271A JPH06509349A (ja) | 1991-08-02 | 1992-08-03 | アンジオテンシン2拮抗活性を有する化合物 |
CA002114621A CA2114621A1 (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine ii antagonistic activity |
AU23873/92A AU668357B2 (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine II antagonistic activity |
US08/193,025 US5565464A (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine II antagonistic activity |
HU9400267A HUT67666A (en) | 1991-08-02 | 1992-08-03 | Biphenylil methyl pyrimidine derivatives having angiotensine ii antagonistic activity and pharmaceutical compositions containing them |
PL92302346A PL174986B1 (pl) | 1991-08-02 | 1992-08-03 | Sposób wytwarzania związków o działaniu antagonistycznym względem angiotensyny II |
FI940355A FI940355A0 (fi) | 1991-08-02 | 1994-01-25 | Yhdisteet, joilla on angiotensiini II:ta vastustava vaikutus |
NO940321A NO940321L (no) | 1991-08-02 | 1994-01-31 | Forbindelser med angiotensin II - antagonistisk aktivitet |
BG98430A BG61692B1 (bg) | 1991-08-02 | 1994-01-31 | Съединения с ангиотензин ii антагонистична активност |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI912182A IT1250749B (it) | 1991-08-02 | 1991-08-02 | Composti eterociclici ad attivita' a ii antagonista |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI912182A0 ITMI912182A0 (it) | 1991-08-02 |
ITMI912182A1 ITMI912182A1 (it) | 1993-02-03 |
IT1250749B true IT1250749B (it) | 1995-04-21 |
Family
ID=11360517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI912182A IT1250749B (it) | 1991-08-02 | 1991-08-02 | Composti eterociclici ad attivita' a ii antagonista |
Country Status (14)
Country | Link |
---|---|
US (1) | US5565464A (it) |
EP (1) | EP0641329A1 (it) |
JP (1) | JPH06509349A (it) |
AU (1) | AU668357B2 (it) |
BG (1) | BG61692B1 (it) |
CA (1) | CA2114621A1 (it) |
CZ (1) | CZ16994A3 (it) |
FI (1) | FI940355A0 (it) |
HU (1) | HUT67666A (it) |
IT (1) | IT1250749B (it) |
PL (1) | PL174986B1 (it) |
RO (1) | RO113987B1 (it) |
SK (1) | SK10694A3 (it) |
WO (1) | WO1993003018A1 (it) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100300566B1 (ko) * | 1994-09-17 | 2001-11-22 | 조생현 | 피리미디논유도체와그의제조방법및용도 |
IT1283620B1 (it) * | 1996-04-19 | 1998-04-22 | Luso Farmaco Inst | "pirimidin-4-oni n-3 sostituiti ad attivita' aii antagonista" |
CA2176058C (en) * | 1996-05-08 | 1999-03-02 | William Nicholas Goodway | Three-dimensional seismic acquisition |
KR20010031557A (ko) * | 1997-10-31 | 2001-04-16 | 추후제출 | 치환 아닐리드 |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
JP2007504136A (ja) * | 2003-08-28 | 2007-03-01 | ニトロメッド インコーポレーティッド | ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法 |
US20090012057A1 (en) * | 2005-02-28 | 2009-01-08 | Nitromed, Inc. | Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use |
WO2006099058A2 (en) * | 2005-03-09 | 2006-09-21 | Nitromed, Inc. | Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
EP1890703B1 (en) * | 2005-06-14 | 2016-05-11 | Taigen Biotechnology | Pyrimidine compounds as chemokine receptors inhibitors |
US8193206B2 (en) | 2005-06-14 | 2012-06-05 | Taigen Biotechnology Co., Ltd. | Pyrimidine compounds |
US7803940B2 (en) * | 2006-11-24 | 2010-09-28 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases |
EP2256115A1 (en) * | 2006-11-24 | 2010-12-01 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound and use thereof |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CN101772513B (zh) | 2007-06-04 | 2013-11-13 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
PL2384327T3 (pl) | 2009-01-30 | 2013-12-31 | Takeda Pharmaceuticals Co | Związki ze skondensowanym pierścieniem i ich zastosowanie |
EP2420501A4 (en) * | 2009-04-17 | 2012-08-29 | Kowa Co | NEW COMPOUNDS WITH 3-HETEROARYLPYRIMIDIN-4- (3H) -ONE STRUCTURE AND PHARMACEUTICAL PREPARATION THEREWITH |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
WO2014197720A2 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
KR102131022B1 (ko) * | 2018-07-12 | 2020-07-07 | 보령제약 주식회사 | 피리미디논 유도체 화합물 및 이의 용도 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424317A3 (en) * | 1989-10-19 | 1991-09-25 | Ciba-Geigy Ag | Pyrimidines |
EP0435827A3 (en) * | 1989-12-28 | 1991-11-13 | Ciba-Geigy Ag | Diaza compounds |
EP0522038A4 (en) * | 1990-03-30 | 1993-05-26 | Merck & Co. Inc. | Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
US5166206A (en) * | 1990-03-30 | 1992-11-24 | Merck & Co., Inc. | Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
IE912114A1 (en) * | 1990-07-02 | 1992-01-15 | Union Pharma Scient Appl | Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present |
-
1991
- 1991-08-02 IT ITMI912182A patent/IT1250749B/it active IP Right Grant
-
1992
- 1992-08-03 WO PCT/EP1992/001753 patent/WO1993003018A1/en not_active Application Discontinuation
- 1992-08-03 CZ CZ94169A patent/CZ16994A3/cs unknown
- 1992-08-03 PL PL92302346A patent/PL174986B1/pl unknown
- 1992-08-03 HU HU9400267A patent/HUT67666A/hu unknown
- 1992-08-03 JP JP5503271A patent/JPH06509349A/ja active Pending
- 1992-08-03 SK SK106-94A patent/SK10694A3/sk unknown
- 1992-08-03 EP EP92916506A patent/EP0641329A1/en not_active Withdrawn
- 1992-08-03 CA CA002114621A patent/CA2114621A1/en not_active Abandoned
- 1992-08-03 RO RO94-00144A patent/RO113987B1/ro unknown
- 1992-08-03 AU AU23873/92A patent/AU668357B2/en not_active Ceased
- 1992-08-03 US US08/193,025 patent/US5565464A/en not_active Expired - Fee Related
-
1994
- 1994-01-25 FI FI940355A patent/FI940355A0/fi unknown
- 1994-01-31 BG BG98430A patent/BG61692B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
ITMI912182A0 (it) | 1991-08-02 |
ITMI912182A1 (it) | 1993-02-03 |
HU9400267D0 (en) | 1994-05-30 |
WO1993003018A1 (en) | 1993-02-18 |
CZ16994A3 (en) | 1994-06-15 |
HUT67666A (en) | 1995-04-28 |
BG98430A (bg) | 1994-09-30 |
FI940355A (fi) | 1994-01-25 |
SK10694A3 (en) | 1994-12-07 |
PL174986B1 (pl) | 1998-10-30 |
FI940355A0 (fi) | 1994-01-25 |
CA2114621A1 (en) | 1993-02-18 |
RO113987B1 (ro) | 1998-12-30 |
AU668357B2 (en) | 1996-05-02 |
EP0641329A1 (en) | 1995-03-08 |
AU2387392A (en) | 1993-03-02 |
BG61692B1 (bg) | 1998-03-31 |
JPH06509349A (ja) | 1994-10-20 |
US5565464A (en) | 1996-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1250749B (it) | Composti eterociclici ad attivita' a ii antagonista | |
ATE194335T1 (de) | 4,5-diaryloxazol-derivate | |
MY108885A (en) | Heterocyclic-cyclic amine derivatives. | |
DE69232022D1 (de) | Naphthyridinderivate als Angiotensin-II-Antagonist-Inhibitoren | |
BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
MX9605128A (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
TR199701654T1 (xx) | 4-Fenilaminotiyazol t�revleri. | |
AU2002246728A1 (en) | Carboline derivatives | |
FI913478A0 (fi) | Diazinderivat. | |
TR200201205T2 (tr) | N-ikame edilmiş karbamoiloksialkil-azolyum türevleri. | |
ATE346067T1 (de) | Carbolinderivate | |
DE60121345D1 (de) | Alkylierte imidazopyridinderivate | |
DE69823493D1 (de) | Tetrahydropyridoverbindungen | |
ES8608503A1 (es) | Procedimiento para la fabricacion de nuevos derivados de la cumarina | |
DE69418744T2 (de) | Verwendung von Pregnanderivaten zur Behandlung von Tumoren | |
TW350838B (en) | Quinoline derivatives | |
DK0579968T3 (da) | 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
DE69330601T2 (de) | Serotoninergische ergolin derivate | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
DE59108566D1 (de) | Heteroarylmethylbenzole-Aromatasehemmer | |
MY133140A (en) | N-substituted azabicycloheptane derivatives, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960826 |